Description overdue on 27.01.2012

Anti-inflammatory . As part of the drug contains the active concentrate from the Black Sea shad, anchovy Black Sea, the Black Sea whiting and small marine fish. The drug has analgesic, anti-inflammatory, chondroprotective effects. The mechanism of action of the drug Alflutop directed to inhibition of the activity hyaluronidase , Decrease capillary permeability, stimulation of recovery processes in the articular cartilage tissue, interstitial tissue recovery, preventing the destruction of the macromolecular structure of the main substances in the connective tissue. Use of the drug is accompanied by a decrease in the intensity of pain when walking, active movements, alone, the drug reduces the severity contractures . Alflutop reduces the number of leukocytes, globulins , Firinogena, seromucoid, C-reactive protein   consisting of synovial fluid, ESR . Under the influence of the drug expands the range of motion in the joints, increased physical activity. The drug increases Alflutop hyaluronic acid   composed of synovial fluid   half after a six-month course of therapy. The drug is available as a solution.

Indications and contraindications:

Alflutop effectively used for the treatment of primary, secondary osteoarthritis of different localization: arthrosis of small joints, gonartroz   (knee-joint), coxarthrosis   (hip). The drug is prescribed for parodontopatii , Violations of chondral ossification and endochondral origin, traumatic dysostosis . spondylosis , Osteochondrosis. Alflutop contraindicated in animals hypersensitive to the components of the drug, the drug is not indicated during pregnancy, breastfeeding. Children and adolescents prescribed with caution.

Side effect:

After intraarticular injection Alflutop may experience increased pain in the joints, marked myalgia . arthralgia . At the injection site may occur itching, redness.

Mode of application:

Alflutop administered intramuscularly at the dose of 10 mg daily treatment capacity of 20 days. When defeat of large joints medicament recommended for intraarticular injection at a dosage of 20 mg three times daily in the affected joint cavity, then move on intramuscular injection of a medicament for three weeks. After 4-6 months, repeat the course.